From https://www.rxlist.com/dupixent-drug.htm
"Dupilumab is produced by recombinant DNA technology in Chinese Hamster Ovary cell suspension culture."
Administering Dupilumab appears a tad complicated:
"DUPIXENT is administered by subcutaneous injection."
"During the 52-week treatment period of concomitant therapy trial (Trial 3), conjunctivitis was reported in 16% of the DUPIXENT 300 mg Q2W + TCS group (20 per 100 subject-years) and in 9% of the placebo + TCS group (10 per 100 subject-years) [see WARNINGS AND PRECAUTIONS]."
So IMO results so far suggest BTX 1204 will be generally superior to DUPIXENT.
DYOR, I am not a doctor although I am currently attending my grand-children's sick cat, assisted by a doctor.
- Forums
- ASX - By Stock
- Ann: Ethics Approval for Phase 2 Atopic Dermatitis Study Received
From https://www.rxlist.com/dupixent-drug.htm "Dupilumab is...
-
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
36.0¢ |
Change
-0.005(1.37%) |
Mkt cap ! $707.4M |
Open | High | Low | Value | Volume |
36.5¢ | 37.0¢ | 36.0¢ | $391.8K | 1.080M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 160000 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 11013 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 423267 | 0.105 |
23 | 1189777 | 0.100 |
1 | 10111 | 0.099 |
1 | 50000 | 0.098 |
1 | 50000 | 0.097 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 555657 | 10 |
0.115 | 560304 | 6 |
0.120 | 829451 | 14 |
0.125 | 1083838 | 12 |
0.130 | 498290 | 12 |
Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
BOT (ASX) Chart |